logo
Select company
Select metric
Ticker Information

Ticker

PALI

Company Name

PALISADE BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PALISADE BIO INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PALI - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -11.71M0%$ 0
3/31/2025$ -13.01M0%$ 0
12/31/2024$ -14.31M0%$ 0
9/30/2024$ -13.95M0%$ 0
6/30/2024$ -14.06M0%$ 0
3/31/2024$ -13.38M0%$ 0
12/31/2023$ -12.2M-4878%$ 250K
9/30/2023$ -12.93M-5171.6%$ 250K
6/30/2023$ -13.31M-5323.6%$ 250K
3/31/2023$ -12.24M-4894.4%$ 250K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for PALISADE BIO INC is calculated as follows: EBITDA [ $ -13.75M ] / Revenues [ $ 13.52K ]
(=) EBITDA % [ -101734.08% ]

PALI - EBITDA Margin, Last 5 years

-1300623.6%

Minimum

Sep 30, 2021

-4878%

Maximum

Dec 31, 2023

-276363.95%

Average

-101734.08%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%